Patents by Inventor Fabio LA NEVE

Fabio LA NEVE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230151421
    Abstract: The invention relates to a method for determining the clonality of a master cell bank (MCB) in which a transgene has been inserted. The method involves a combination of sequencing methodology and bioinformatic analysis, performed on multiple subclones originating from a common MCB, to establish a reliable set of reference transgene insertion regions in one reference subclone, and corresponding sets of comparative transgene insertion regions in one or more other subclones originating from the same MCB. Based on the degree of congruity between reference and comparative transgene insertion regions, the MCB is determined to be either monoclonal or polyclonal.
    Type: Application
    Filed: October 18, 2022
    Publication date: May 18, 2023
    Inventors: Fabio LA NEVE, Georg FEGER, Emiliano TOSO
  • Publication number: 20220290259
    Abstract: Provides herein is a method for identifying the specific cell lineage of cells in culture comprising the steps of determining from the nucleic acid molecules isolated from said recombinant cells in culture the presence of polymorphisms or SNPs at at least 5 different positions within at least five genes contained in said nucleic acid molecules, obtaining a genetic profile from the determination of the previous step, and identiyfing the cell lineage of said cells in culture from said genetic profile, and wherein the recombinant cells produce a recombinant protein.
    Type: Application
    Filed: June 26, 2019
    Publication date: September 15, 2022
    Inventors: ALESSIA BACHMANN, FABIO LA NEVE
  • Publication number: 20180327830
    Abstract: The invention relates to a method for determining the clonality of a master cell bank (MCB) in which a transgene has been inserted. The method involves a combination of sequencing methodology and bioinformatic analysis, performed on multiple subclones originating from a common MCB, to establish a reliable set of reference transgene insertion regions in one reference subclone, and corresponding sets of comparative transgene insertion regions in one or more other subclones originating from the same MCB. Based on the degree of congruity between reference and comparative transgene insertion regions, the MCB is determined to be either monoclonal or polyclonal.
    Type: Application
    Filed: December 1, 2016
    Publication date: November 15, 2018
    Inventors: Fabio LA NEVE, Georg FEGER, Emiliano TOSO